drugset / Trial / NCT00838058

A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.

NCT00838058

Phase 1 Completed 11 enrolled Pfizer
RandomizedCrossoverOpen-label

Summary

The study will try, in 2 separate parts, each using 12 research subjects, to see how a new form of the pill CE 224,535 gets released into the bloodstream and whether that is affected by food. In each part, subjects will switch among 4 treatment periods to take either different forms of the pill(s) or the same form either after fasting or eating a meal. The second part will only happen depending on whether the sponsor believes it is needed and will use separate subject than the first part.

Timeline

Start
2009-01
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject CE-224,535 Small molecule 250 mg
Subject CE-224,535 Small molecule 500 mg
Subject CE-224,535 Small molecule 1000 mg

Indications